Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Thyroid Disorder Market Research Report Information by Type (Hypothyroidism and Hyperthyroidism), Treatment (Medications, Radioactive Iodine Therapy, and Surgery), Route of Administration (Oral, Intravenous and others), End-User (Hospitals, Clinics, and others) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2032

ID: MRFR/Pharma/2031-CR | 118 Pages | Author: Rahul Gotadki| July 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 18

3.2 Scope Of The Study 18

3.3 List Of Assumptions 19

3.4 Market Structure 19

4 Research Methodology

4.1 Research Process 21

4.2 Primary Research 21

4.3 Secondary Research 22

4.4 Market Size Estimation 23

4.5 Forecast Model 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 26

5.2.1 Increasing Prevalence Of Thyroid Diseases 26

5.2.2 Rising Awareness Of Thyroid 26

5.2.3 Favorable Reimbursement And Funding Policies 27

5.2.4 Drivers Impact Analysis 27

5.3 Restraint 28

5.3.1 High Cost Of Treatment Procedures Such As Radioactive Iodine (RAI) Therapy 28

5.3.2 Side-Effects Related To Available Therapeutics 28

5.3.3 Restraints Impact Analysis 28

5.4 Opportunity 29

5.4.1 Emerging Markets Of Asia-Pacific 29

5.5 Macroeconomic Indicators 29

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 31

6.1.1 Threat Of New Entrants 32

6.1.2 Bargaining Power Of Suppliers 32

6.1.3 Threat Of Substitutes 32

6.1.4 Bargaining Power Of Buyers 32

6.1.5 Intensity Of Rivalry 32

7 Thyroid Disorder Market, By Type

7.1 Overview 34

7.1.1 Introduction 34

7.1.2 Hypothyroidism 35

7.1.3 Hyperthyroidism 36

8 Thyroid Disorder Market, By Treatment

8.1 Overview 38

8.1.1 Introduction 38

8.1.2 Medications 39

8.1.3 Radioactive Iodine Therapy 40

8.1.4 Surgery 41

9 Thyroid Disorder Market, By Route Of Administration

9.1 Overview 43

9.1.1 Oral 44

9.1.2 Intravenous 45

10 Thyroid Disorder Market, By End User

10.1 Overview 47

10.1.1 Hospitals 48

10.1.2 Clinics 49

11 Global Thyroid Disorder Market, By Region

11.1 Overview 51

11.2 Americas 52

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.2.1 North America 55

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.2.1.1 US 57

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.2.1.2 Canada 58

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.2.2 Latin America 60

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3 Europe 62

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1 Western Europe 64

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.1 Germany 66

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.2 France 68

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.3 UK 69

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.4 Italy 71

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.5 Spain 73

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.1.6 Rest Of Western Europe 74

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.3.2 Eastern Europe 76

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4 Asia-Pacific 78

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.1 Japan 81

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.2 China 82

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.3 India 84

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.4 South Korea 86

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.5 Australia 87

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.4.6 Rest Of Asia-Pacific 89

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.5 Middle East & Africa 91

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.5.1 Middle East 93

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

11.5.2 Africa 95

Thyroid Disorder Market, By Type

Thyroid Disorder Market, By Treatment

Thyroid Disorder Market, By Route Of Administration

Thyroid Disorder Market, By End User

12 Competitive Landscape

12.1 Company Market Share Analysis 98

12.1.1 Introduction 98

13 Company Profiles

13.1 Pfizer Inc 100

13.1.1 Company Overview 100

13.1.2 Financial Overview 100

13.1.3 Products/Services Offered 101

13.1.4 Key Developments 101

13.1.5 SWOT Analysis 101

13.1.6 Key Strategy 101

13.2 Allergan Inc. 102

13.2.1 Company Overview 102

13.2.2 Financial Overview 102

13.2.3 Products/Services Offered 103

13.2.4 Key Developments 103

13.2.5 SWOT Analysis 103

13.2.6 Key Strategy 103

13.3 AbbVie Inc. 104

13.3.1 Company Overview 104

13.3.2 Financial Overview 104

13.3.3 Products/Services Offering 105

13.3.4 Key Developments 105

13.3.5 SWOT Analysis 105

13.3.6 Key Strategy 105

13.4 Merck KGaA 106

13.4.1 Company Overview 106

13.4.2 Financial Overview 106

13.4.3 Products/Services Offering 107

13.4.4 Key Developments 107

13.4.5 SWOT Analysis 107

13.4.6 Key Strategy 107

13.5 RLC Labs 108

13.5.1 Company Overview 108

13.5.2 Financial Overview 108

13.5.3 Products/Services Offered 108

13.5.4 SWOT Analysis 108

13.5.5 Key Developments 108

13.5.6 Key Strategy 108

13.6 Abbott Laboratories 109

13.6.1 Company Overview 109

13.6.2 Financial Overview 109

13.6.3 Products/Services Offered 110

13.6.4 Key Developments 110

13.6.5 SWOT Analysis 110

13.6.6 Key Strategy 110

13.7 GlaxoSmithKline PLC 111

13.7.1 Company Overview 111

13.7.2 Financial Overview 111

13.7.3 Products/Services Offered 112

13.7.4 Key Developments 112

13.7.5 SWOT Analysis 112

13.7.6 Key Strategy 112

13.8 Mylan 113

13.8.1 Company Overview 113

13.8.2 Financial Overview 113

13.8.3 Products/Services Offered 114

13.8.4 Key Developments 114

13.8.5 SWOT Analysis 114

13.8.6 Key Strategy 114

14 Appendix

14.1 Discussion Blue Print 116

15 List Of Tables

TABLE 1 MARKET SYNOPSIS 16

TABLE 2 LIST OF ASSUMPTIONS 19

TABLE 3 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 35

TABLE 4 GLOBAL THYROID DISORDER MARKET FOR HYPOTHYROIDISM, BY REGION, 2020–2027 (USD MILLION) 35

TABLE 5 GLOBAL THYROID DISORDER MARKET FOR HYPERTHYROIDISM, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 6 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 39

TABLE 7 GLOBAL THYROID DISORDER MARKET FOR MEDICATIONS, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 8 GLOBAL THYROID DISORDER MARKET FOR RADIOACTIVE IODINE THERAPY, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 9 GLOBAL THYROID DISORDER MARKET FOR SURGERY, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 10 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL THYROID DISORDER MARKET FOR ORAL, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 12 GLOBAL THYROID DISORDER MARKET FOR INTRAVENOUS, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 13 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020–2027 (USD MILLION) 48

TABLE 14 GLOBAL THYROID DISORDER MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 15 GLOBAL THYROID DISORDER MARKET FOR CLINICS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 16 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 17 AMERICAS: THYROID DISORDER MARKET, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 18 AMERICAS: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 19 AMERICAS: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 54

TABLE 20 AMERICAS: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 54

TABLE 21 AMERICAS: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 54

TABLE 22 NORTH AMERICA: THYROID DISORDER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55

TABLE 23 NORTH AMERICA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 24 NORTH AMERICA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 55

TABLE 25 NORTH AMERICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 56

TABLE 26 NORTH AMERICA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 56

TABLE 27 US: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 28 US: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 57

TABLE 29 US: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 57

TABLE 30 US: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 58

TABLE 31 CANADA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 32 CANADA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 59

TABLE 33 CANADA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 59

TABLE 34 CANADA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 60

TABLE 35 LATIN AMERICA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 36 LATIN AMERICA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 60

TABLE 37 LATIN AMERICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 61

TABLE 38 LATIN AMERICA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 61

TABLE 39 EUROPE: THYROID DISORDER MARKET, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 40 EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 41 EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 63

TABLE 42 EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 63

TABLE 43 EUROPE: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 64

TABLE 44 WESTERN EUROPE: THYROID DISORDER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 64

TABLE 45 WESTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 46 WESTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 65

TABLE 47 WESTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 65

TABLE 48 WESTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 66

TABLE 49 GERMANY: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 50 GERMANY: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 67

TABLE 51 GERMANY: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 67

TABLE 52 GERMANY: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 67

TABLE 53 FRANCE: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 54 FRANCE: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 68

TABLE 55 FRANCE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 69

TABLE 56 FRANCE: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 69

TABLE 57 UK: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 58 UK: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 70

TABLE 59 UK: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 70

TABLE 60 UK: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 71

TABLE 61 ITALY: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 62 ITALY: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 72

TABLE 63 ITALY: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 72

TABLE 64 ITALY: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 72

TABLE 65 SPAIN: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 66 SPAIN: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 73

TABLE 67 SPAIN: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 74

TABLE 68 SPAIN: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 74

TABLE 69 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 70 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 75

TABLE 71 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 75

TABLE 72 REST OF WESTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 76

TABLE 73 EASTERN EUROPE: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 74 EASTERN EUROPE: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 76

TABLE 75 EASTERN EUROPE: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 77

TABLE 76 EASTERN EUROPE: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 77

TABLE 77 ASIA-PACIFIC: THYROID DISORDER MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79

TABLE 78 ASIA-PACIFIC: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 79 ASIA-PACIFIC: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 80

TABLE 80 ASIA-PACIFIC: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 80

TABLE 81 ASIA-PACIFIC: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 80

TABLE 82 JAPAN: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 83 JAPAN: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 81

TABLE 84 JAPAN: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 82

TABLE 85 JAPAN: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 82

TABLE 86 CHINA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 87 CHINA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 83

TABLE 88 CHINA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 83

TABLE 89 CHINA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 84

TABLE 90 INDIA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 91 INDIA; THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 84

TABLE 92 INDIA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 85

TABLE 93 INDIA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 85

TABLE 94 SOUTH KOREA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 95 SOUTH KOREA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 86

TABLE 96 SOUTH KOREA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 86

TABLE 97 SOUTH KOREA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 87

TABLE 98 AUSTRALIA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 99 AUSTRALIA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 88

TABLE 100 AUSTRALIA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 88

TABLE 101 AUSTRALIA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 88

TABLE 102 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 103 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 89

TABLE 104 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 90

TABLE 105 REST OF ASIA-PACIFIC: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 90

TABLE 106 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY REGION, 2020–2027 (USD MILLION) 91

TABLE 107 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 108 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 92

TABLE 109 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 92

TABLE 110 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 93

TABLE 111 MIDDLE EAST: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 112 MIDDLE EAST: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 94

TABLE 113 MIDDLE EAST: THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 94

TABLE 114 MIDDLE EAST: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 94

TABLE 115 AFRICA: THYROID DISORDER MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 116 AFRICA: THYROID DISORDER MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 95

TABLE 117 AFRICA; THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 96

TABLE 118 AFRICA: THYROID DISORDER MARKET, BY END USER 2020–2027 (USD MILLION) 96

16 List Of Figures

FIGURE 1 GLOBAL THYROID DISORDER MARKET: MARKET STRUCTURE 19

FIGURE 2 RESEARCH PROCESS OF MRFR 21

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 24

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL THYROID DISORDER MARKET 26

FIGURE 5 DRIVERS IMPACT ANALYSIS: GLOBAL THYROID DISORDER MARKET 27

FIGURE 6 RESTRAINTS IMPACT ANALYSIS: GLOBAL THYROID DISORDER MARKET 28

FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL THYROID DISORDER MARKET 31

FIGURE 8 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020 (%) 34

FIGURE 9 GLOBAL THYROID DISORDER MARKET, BY TYPE, 2020 AND 2027 34

FIGURE 10 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020 (%) 38

FIGURE 11 GLOBAL THYROID DISORDER MARKET, BY TREATMENT, 2020 AND 2027 38

FIGURE 12 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020 (%) 43

FIGURE 13 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION, 2020 AND 2027 43

FIGURE 14 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020 (%) 47

FIGURE 15 GLOBAL THYROID DISORDER MARKET, BY END USER, 2020 AND 2027 47

FIGURE 16 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 51

FIGURE 17 GLOBAL THYROID DISORDER MARKET, BY REGION, 2020 (%) 52

FIGURE 18 AMERICAS: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 53

FIGURE 19 EUROPE: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 62

FIGURE 20 ASIA-PACIFIC: THYROID DISORDER MARKET SHARE, BY COUNTRY, 2020 (%) 78

FIGURE 21 MIDDLE EAST AND AFRICA: THYROID DISORDER MARKET SHARE, BY REGION, 2020 (%) 91

FIGURE 22 GLOBAL THYROID DISORDER MARKET, MARKET SHARE ANALYSIS 2020 (%) 98

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Press Release

pr-img

Rising Prevalence of Thyroid Disorders & Demand for New Diagnostic & Treatment Options Ac...

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)